Company Overview
- Website
- epderivatives.com
- Employees
- 3
- Industry
- Financial Services
Financials & Stats
Revenue
$3B
Recent News & Media
Thiazolidinedione-based structure modification of ergosterol peroxide provides thiazolidinedione-conjugated derivatives as potent agents against breast cancer cells through a PI3K/AKT/mTOR pathway
- Nov 20, 2024
- sciencedirect.com
Design and synthesis of novel mitochondria-targeted ergosterol peroxide derivatives as potential anti-cancer agents
- Oct 2, 2024
- sciencedirect.com
Discovery and Optimization of Ergosterol Peroxide Derivatives as Novel Glutaminase 1 Inhibitors for the Treatment of Triple-Negative Breast Cancer
- Sep 14, 2024
- pubmed.ncbi.nlm.nih.gov
Discovery and Optimization of Ergosterol Peroxide Derivatives as Novel Glutaminase 1 Inhibitors for the Treatment of Triple-Negative Breast Cancer
- Sep 14, 2024
- pmc.ncbi.nlm.nih.gov
Early Preclinical Studies of Ergosterol Peroxide and Biological Evaluation of Its Derivatives
- Aug 19, 2024
- pubs.acs.org
Early Preclinical Studies of Ergosterol Peroxide and Biological Evaluation of Its Derivatives
- Aug 19, 2024
- pubs.acs.org
Companies Similar to EP Derivatives
Analyze industry trends and opportunities by examining competitors and companies comparable to EP Derivatives, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 3M | New York, NY | |||
| 3M | 1 | Houston, TX | ||
| 3M | Miami, FL | |||
| 3M | 17 | Nashville, TN | ||
| 3M | 1 | Chicago, IL |